At 48 weeks , cohort A and cohort B patients maintained a 37 % and 62 % increase in ABI compared with baseline , respectively ; 70 % of cohort A and 78 % of cohort B improved by 1 Fontaine classification stage , and the TLR rate was 39 % for cohort A and 20 % for cohort B.